Access and reimbursement for Part B and Part D drugs. Opposition to step therapy requirement in Medicare Advantage. Lobbied against the International Pricing Index model (83 FR 54546). The Prescription Drug STAR Act, H.R. 2113. Support for 340B reform.
MMM - Medicare/Medicaid HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
THE MCMANUS GROUP
610 10th St. NW, Suite 300, Washington, DC, 20001, US
JOHN MCMANUS BARRETT THORNHILL CHRISTINA HOCHUL JOHN MCMANUS BARRETT THORNHILL